The DOI matches its Crossref record; 26 of the 27 references it cites were found in a registry or an index.
Reductive carboxylation supports growth in tumour cells with defective mitochondria
Open accessAbstract
Mitochondrial metabolism provides precursors to build macromolecules in growing cancer cells. In normally functioning tumour cell mitochondria, oxidative metabolism of glucose- and glutamine-derived carbon produces citrate and acetyl-coenzyme A for lipid synthesis, which is required for tumorigenesis. Yet some tumours harbour mutations in the citric acid cycle (CAC) or electron transport chain (ETC) that disable normal oxidative mitochondrial function, and it is unknown how cells from such tumours generate precursors for macromolecular synthesis. Here we show that tumour cells with defective mitochondria use glutamine-dependent reductive carboxylation rather than oxidative metabolism as the major pathway of citrate formation. This pathway uses mitochondrial and cytosolic isoforms of NADP(+)/NADPH-dependent isocitrate dehydrogenase, and subsequent metabolism of glutamine-derived citrate provides both the acetyl-coenzyme A for lipid synthesis and the four-carbon intermediates needed to produce the remaining CAC metabolites and related macromolecular precursors. This reductive, glutamine-dependent pathway is the dominant mode of metabolism in rapidly growing malignant cells containing mutations in complex I or complex III of the ETC, in patient-derived renal carcinoma cells with mutations in fumarate hydratase, and in cells with normal mitochondria subjected to acute pharmacological ETC inhibition. Our findings reveal the novel induction of a versatile glutamine-dependent pathway that reverses many of the reactions of the canonical CAC, supports tumour cell growth, and explains how cells generate pools of CAC intermediates in the face of impaired mitochondrial metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, checkpoint kinase 1 (CHK1) inhibitors625–627 and glutaminase (GLS) inhibitors628–634 are also considered potential candidates for treating Myc-overexpressing cancers.”
From Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials (2023) · cites this paper as [630]
In the citing paper
“In the context of constitutive HIF-2α stabilization75 or a defective mitochondrial electron transport chain76, glutamine-derived α-KG is reductively carboxylated through the consumption of NADPH by IDH2 to generate citrate.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [76]
In the citing paper
“Previous reports showed that reductive carboxylation is a critical pathway to support the growth of tumor cells under hypoxia (Metallo, 2012; Mullen, 2012).”
From Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism (2016) · cites this paper as Mullen, 2012
In the citing paper
“The upregulation of the reductive carboxylation pathway enhances cancer cells proliferation (Metallo, 2012; Mullen, 2012; Wise et al., 2011).”
From Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism (2016) · cites this paper as Mullen, 2012
In the citing paper
“For example, under conditions of hypoxia or impaired mitochondrial respiration, certain reactions of the TCA cycle reverse to support glutamine-dependent reductive carboxylation (92, 122, 123).”
From Regulation and function of the mammalian tricarboxylic acid cycle (2023) · cites this paper as [123]
In the citing paper
“Citrate is generated by citrate synthase (CS) or through the reduction of α-ketoglutarate by isocitrate dehydrogenase (IDH).79–81”
From The multifaceted contributions of mitochondria to cellular metabolism (2018) · cites this paper as [80]
In the citing paper
“Glutamine can contribute carbon to fatty acid synthesis via reductive carboxylation or oxidative glutaminolysis.”
From Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier (2014) · cites this paper as Mullen et al., 2012
In the citing paper
“The former pathway is highly active in cells proliferating under hypoxia or those with a compromised respiratory chain (Metallo et al., 2012; Mullen et al., 2012; Scott et al., 2011; Wise et al., 2011), while the latter pathway has been observed in B cell lymphoma (Le et al., 2012).”
From Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier (2014) · cites this paper as Mullen et al., 2012
In the citing paper
“Although oxidation of glutamine-derived α-KG in the TCA cycle serves as a minor source of lipogenic acetyl-CoA under normal growth conditions, α-KG can be converted to citrate through reductive carboxylation under conditions of stress such as hypoxia or mitochondrial dysfunction (70–72).”
From Fueling Immunity: Insights into Metabolism and Lymphocyte Function (2013) · cites this paper as [70]
In the citing paper
“In place of oxidative metabolism of both glucose and glutamine, these cancers preferentially perform reductive and carboxylating biosynthetic reactions from glutamine carbon (Le et al., 2012; Metallo et al., 2012; Mullen et al., 2012; Wise et al., 2011).”
From Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate (2012) · cites this paper as Mullen et al., 2012
In the citing paper
“Recently three independent reports implicated IDH-dependent reductive carboxylation as playing a particularly important role in proliferating cells that exhibit decreased flux of glucose-derived pyruvate into the mitochondria. This occurs in hypoxic cells or in cells harboring defects in mitochondrial oxidative phosphorylation (Metallo et al., 2012; Mullen et al., 2012; Wise et al., 2011).”
From Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate (2012) · cites this paper as Mullen et al., 2012
In the citing paper
“tumor cells with mutations in the TCA cycle or ETC (Mullen et al., 2011), or with hypoxia-induced suppression of oxidative metabolism (Metallo et al., 2011; Scott et al., 2011; Wise et al., 2011) use reductive carboxylation of α-KG to produce citrate and other precursors during growth.”
From Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us? (2012) · cites this paper as Mullen et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Branched tricarboxylic acid metabolism in Plasmodium falciparum
Olszewski, K. L., Mather, M. W., Morrisey, J. M., Garcia, B. A., Vaidya, A. B., Rabinowitz, J. D., & Llinás, M. (2010) · Nature · doi:10.1038/nature09301 · Cited by 124
RetractedUnderstanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
Self-citationGao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124
Ward, P. S., Patel, J., Wise, D. R., Abdel-Wahab, O., Bennett, B. D., Coller, H. A., Cross, J. R., Fantin, V. R., Hedvat, C. V., Perl, A. E., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.01.020 · Cited by 2,020
Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity
Weinberg, F., Hamanaka, R., Wheaton, W. W., Weinberg, S., Joseph, J., Lopez, M., Kalyanaraman, B., Mutlu, G. M., Budinger, G. R. S., & Chandel, N. S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003428107 · Cited by 1,742
Self-citationMutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638
The Multiple Leiomyoma Consortium (2002) · Nature Genetics · doi:10.1038/ng849 · Cited by 1,635
El-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.223 · Cited by 1,399
Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer
DeBerardinis, R. J., & Cheng, T. (2010) · Oncogene · doi:10.1038/onc.2009.358 · Cited by 1,365
Self-citation
Flagged first, then by citations
1 of the 27 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 401–500 of 1,000
Sirtuins and the Metabolic Hurdles in Cancer
German, N. J., & Haigis, M. C. (2015) · Current Biology · doi:10.1016/j.cub.2015.05.012 · Cited by 84
Nitric oxide is a positive regulator of the Warburg effect in ovarian cancer cells
Caneba, C. A., Yang, L., Baddour, J., Curtis, R. N., Win, J., Hartig, S. M., Marini, J. C., & Nagrath, D. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.264 · Cited by 84
Honjo, H., Kaira, K., Miyazaki, T., Yokobori, T., Kanai, Y., Nagamori, S., Oyama, T., Asao, T., & Kuwano, H. (2016) · Journal of Surgical Oncology · doi:10.1002/jso.24160 · Cited by 83
Metabolic checkpoints in immune cell reprogramming: rewiring immunometabolism for cancer therapy
Lv, Y., Li, Z., Liu, S., Zhou, Z., Jinling, S., Ba, Y., Weng, S., Zuo, A., Xu, H. W., Luo, P., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02407-6 · Cited by 93
Extracellular Flux Analysis to Monitor Glycolytic Rates and Mitochondrial Oxygen Consumption
Pelletier, M., Billingham, L. K., Ramaswamy, M., & Siegel, R. M. (2014) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-416618-9.00007-8 · Cited by 85
Jiang, L., Boufersaoui, A., Yang, C., Ko, B., Rakheja, D., Guevara, G., Hu, Z., & DeBerardinis, R. J. (2016) · Metabolic Engineering · doi:10.1016/j.ymben.2016.11.004 · Cited by 84
Self-citationCancer cells depend on environmental lipids for proliferation when electron acceptors are limited
Li, Z., Ji, B. W., Dixit, P. D., Tchourine, K., Lien, E. C., Hosios, A. M., Abbott, K. L., Rutter, J. C., Westermark, A. M., Gorodetsky, E. F., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00588-8 · Cited by 81
Self-citationZwaans, B. M. M., & Lombard, D. B. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.016287 · Cited by 81
Strategies to Reverse Hypoxic Tumor Microenvironment for Enhanced Sonodynamic Therapy
Li, J., Yue, Z., Tang, M., Wang, W., Sun, Y., Sun, T., & Chen, C. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202302028 · Cited by 81
Spatial single-cell isotope tracing reveals heterogeneity of de novo fatty acid synthesis in cancer
Buglakova, E., Ekelöf, M., Schwaiger-Haber, M., Schlicker, L., Molenaar, M. R., Shahraz, M., Stuart, L., Eisenbarth, A., Hilsenstein, V., Patti, G. J., et al. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01118-4 · Cited by 81
Novel drugs that target the metabolic reprogramming in renal cell cancer
van der Mijn, J. C., Panka, D. J., Geissler, A. K., Verheul, H. M. W., & Mier, J. W. (2016) · Cancer & Metabolism · doi:10.1186/s40170-016-0154-8 · Cited by 83
Ho, H., Lin, Y.-T., Lin, G., Wu, P., & Cheng, M. (2017) · Redox Biology · doi:10.1016/j.redox.2017.04.035 · Cited by 81
Myc promotes glutaminolysis in human neuroblastoma through direct activation of glutaminase 2
Xiao, D., Ren, P., Su, H., Yue, M., Xiu, R., Hu, Y., Liu, H., & Qing, G. (2015) · Oncotarget · doi:10.18632/oncotarget.5821 · Cited by 80
Mechanisms of redox metabolism and cancer cell survival during extracellular matrix detachment
Hawk, M. A., & Schafer, Z. T. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.tm117.000260 · Cited by 82
FoxO transcription factors in mitochondrial homeostasis
Cheng, Z. (2022) · Biochemical Journal · doi:10.1042/bcj20210777 · Cited by 81
Shigeta, K., Hasegawa, M., Hishiki, T., Naito, Y., Baba, Y., Mikami, S., Matsumoto, K., Mizuno, R., Miyajima, A., Kikuchi, E., et al. (2023) · The EMBO Journal · doi:10.15252/embj.2022110620 · Cited by 82
Hypoxia induces a lipogenic cancer cell phenotype via HIF1α-dependent and -independent pathways
Valli, A., Rodriguez, M., Moutsianas, L., Fischer, R., Fedele, V., Huang, H.-L., Van Stiphout, R., Jones, D., Mccarthy, M., Vinaxia, M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3058 · Cited by 79
Excessive Gluconeogenesis Causes the Hepatic Insulin Resistance Paradox and Its Sequelae
Onyango, A. N. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e12294 · Cited by 80
Adrenal Nodular Hyperplasia in Hereditary Leiomyomatosis and Renal Cell Cancer
Shuch, B. M., Ricketts, C. J., Vocke, C. D., Valera, V., Chen, C. C., Gautam, R., Gupta, G. N., Gómez-Macias, G. S., Merino, M. J., Bratslavsky, G., et al. (2012) · The Journal of Urology · doi:10.1016/j.juro.2012.07.139 · Cited by 83
Self-citationMutant IDH1 Enhances the Production of 2-Hydroxyglutarate Due to Its Kinetic Mechanism
Rendina, A. R., Pietrak, B., Smallwood, A. M., Zhao, H., Qi, H., Quinn, C. J., Adams, N. D., Concha, N. O., Duraiswami, C., Thrall, S. H., et al. (2013) · Biochemistry · doi:10.1021/bi400514k · Cited by 81
Metabolism during ECM Detachment: Achilles Heel of Cancer Cells?
Mason, J. A., Hagel, K. R., Hawk, M. A., & Schafer, Z. T. (2017) · Trends in Cancer · doi:10.1016/j.trecan.2017.04.009 · Cited by 78
Gregory, C. D., & Dransfield, I. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01111 · Cited by 79
Mutations in the Isocitrate Dehydrogenase Genes IDH1 and IDH2 in Tumors
Schaap, F. G., French, P. J., & Bovée, J. V. M. G. (2012) · Advances in Anatomic Pathology · doi:10.1097/pap.0b013e31827b654d · Cited by 80
Autophagy and oxidative stress in gliomas with IDH1 mutations
Gilbert, M. R., Liu, Y., Neltner, J. H., Pu, H., Morris, A. J., Sunkara, M., Pittman, T. A., Kyprianou, N., & Horbinski, C. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1194-6 · Cited by 78
Broekgaarden, M., Anbil, S. R., Bulin, A., Obaid, G., Mai, Z., Baglo, Y., Rizvi, I., & Hasan, T. G. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119421 · Cited by 78
Fatty Acid Synthesis Is Indispensable for Survival of Human Pluripotent Stem Cells
Tanosaki, S., Tohyama, S., Fujita, J., Someya, S., Hishiki, T., Matsuura, T., Nakanishi, H., Ohto‐Nakanishi, T., Akiyama, T., Morita, Y., et al. (2020) · iScience · doi:10.1016/j.isci.2020.101535 · Cited by 78
Metabolic Reprogramming Induces Germinal Center B Cell Differentiation through Bcl6 Locus Remodeling
Haniuda, K., Fukao, S., & Kitamura, D. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108333 · Cited by 79
Hansen, G. E., & Gibson, G. E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012403 · Cited by 77
Targeting Metabolism to Induce Cell Death in Cancer Cells and Cancer Stem Cells
Pecqueur, C., Oliver, L., Oizel, K., Lalier-Bretaudeau, L., & Vallette, F. M. (2013) · International Journal of Cell Biology · doi:10.1155/2013/805975 · Cited by 83
Limits of aerobic metabolism in cancer cells
Fernández-de-Cossio-Díaz, J., & Vázquez, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-14071-y · Cited by 77
Amoedo, N. D., Obre, E., & Rossignol, R. (2017) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2017.02.005 · Cited by 76
Exploiting tumor metabolism: challenges for clinical translation
Heiden, M. G. V. (2013) · Journal of Clinical Investigation · doi:10.1172/jci72391 · Cited by 79
Mosaoa, R., Kasprzyk-Pawelec, A., Fernandez, H. R., & Avantaggiati, M. L. (2021) · Biomolecules · doi:10.3390/biom11020141 · Cited by 80
The Acetate/ACSS2 Switch Regulates HIF-2 Stress Signaling in the Tumor Cell Microenvironment
Chen, R., Xu, M., Nagati, J. S., Hogg, R. T., Das, A., Gerard, R. D., & Garcia, J. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116515 · Cited by 76
MicroRNAs as regulators of mitochondrial function: Role in cancer suppression
Tomasetti, M., Neužil, J., & Dong, L. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.09.002 · Cited by 78
Xie, M., & Roy, R. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.07.016 · Cited by 78
Mitochondrial Metabolism: Yin and Yang for Tumor Progression
Valcárcel-Jiménez, L., Gaude, E., Torrano, V., Frezza, C., & Carracedo, A. (2017) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2017.06.004 · Cited by 78
Role of FOXO Transcription Factors in Cancer Metabolism and Angiogenesis
Farhan, M., Silva, M., Xing, X., Huang, Y., & Zheng, W. (2020) · Cells · doi:10.3390/cells9071586 · Cited by 79
Yeast and cancer cells – common principles in lipid metabolism
Natter, K., & Kohlwein, S. D. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.09.003 · Cited by 78
Kurelac, I., Iommarini, L., Vatrinet, R., Amato, L. B., Luise, M. D., Leone, G., Girolimetti, G., Ganesh, N. U., Bridgeman, V. L., Ombrato, L., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08839-1 · Cited by 75
Cancer Metabolism: A Modeling Perspective
Ghaffari, P., Mardinoğlu, A., & Nielsen, J. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00382 · Cited by 76
VDAC–Tubulin, an Anti-Warburg Pro-Oxidant Switch
Maldonado, E. N. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00004 · Cited by 76
Hypoxia and cancer cell metabolism
Huang, D., Li, C., & Zhang, H. (2014) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmt148 · Cited by 73
Mitochondria in cancer metabolism, an organelle whose time has come?
Anderson, R. G., Ghiraldeli, L. P., & Pardee, T. S. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.05.005 · Cited by 76
Fatty Acid Synthesis in Prostate Cancer: Vulnerability or Epiphenomenon?
Sena, L. A., & Denmeade, S. R. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-1392 · Cited by 78
Quantitative analysis of metabolic fluxes in brown fat and skeletal muscle during thermogenesis
Park, G. S. H., Haley, J. A., Le, J., Jung, S. M., Fitzgibbons, T. P., Korobkina, E. D., Li, H., Fluharty, S. M., Chen, Q., Spinelli, J. B., et al. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00825-8 · Cited by 74
The Tricarboxylic Acid Cycle at the Crossroad Between Cancer and Immunity
Scagliola, A., Mainini, F., & Cardaci, S. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7974 · Cited by 75
Changes in NAD and Lipid Metabolism Drive Acidosis-Induced Acute Kidney Injury
Bugarski, M., Ghazi, S., Polesel, M., Martins, J. R., & Hall, A. M. (2021) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020071003 · Cited by 72
VDAC Modulation of Cancer Metabolism: Advances and Therapeutic Challenges
Heslop, K. A., Milesi, V., & Maldonado, E. N. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.742839 · Cited by 77
Metabolic adaptations in prostate cancer
Pujana-Vaquerizo, M., Bozal‐Basterra, L., & Carracedo, A. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02762-z · Cited by 73
Metabolic Reprogramming of the Host Cell by Human Adenovirus Infection
Prusinkiewicz, M. A., & Mymryk, J. S. (2019) · Viruses · doi:10.3390/v11020141 · Cited by 72
Hu, Q., Dai, J., Zhang, Z., Yu, H., Zhang, J., Zhu, X., Qin, Y., Zhang, L., & Zhang, P. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-1999 · Cited by 71
Lee, W. D., Mukha, D., Aizenshtein, E., & Shlomi, T. (2019) · Nature Communications · doi:10.1038/s41467-019-09352-1 · Cited by 70
van der Kolk, B. W., Saari, S., Lovrić, A., Arif, M., Alvarez, M., Ko, A., Miao, Z., Sahebekhtiari, N., Muniandy, M., Heinonen, S., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100226 · Cited by 72
Urbanczyk, S., Baris, O. R., Hofmann, J., Taudte, R. V., Guegen, N., Golombek, F., Castiglione, K., Meng, X., Bözec, A., Thomas, J., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110912 · Cited by 70
Nutrient sensors and their crosstalk
Sung, Y., Yu, Y. C., & Han, J. M. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01006-z · Cited by 73
Combining DI-ESI–MS and NMR datasets for metabolic profiling
Marshall, D. D., Lei, S., Worley, B., Huang, Y., García‐García, A., Franco, R., Dodds, E. D., & Powers, R. (2014) · Metabolomics · doi:10.1007/s11306-014-0704-4 · Cited by 70
Allosteric Mutant IDH1 Inhibitors Reveal Mechanisms for IDH1 Mutant and Isoform Selectivity
Xie, X., Baird, D., Bowen, K. E., Čápka, V., Chen, J., Chenail, G., Cho, Y., Dooley, J., Farsidjani, A., Fortin, P. D., et al. (2017) · Structure · doi:10.1016/j.str.2016.12.017 · Cited by 70
Alternative assembly of respiratory complex II connects energy stress to metabolic checkpoints
Bezawork‐Geleta, A., Wen, H., Dong, L., Yan, B., Vider, J., Boukalová, Š., Krobova, L., Vanova, K. H., Zobalová, R., Sobol, M. A., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04603-z · Cited by 73
Glycine decarboxylase maintains mitochondrial protein lipoylation to support tumor growth
Mukha, D., Fokra, M., Feldman, A., Sarvin, B., Sarvin, N., Nevo-Dinur, K., Besser, E., Hallo, E., Aizenshtein, E., Schug, Z. T., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.04.006 · Cited by 69
The Role of Extracellular Vesicles in Metabolic Reprogramming of the Tumor Microenvironment
Fridman, E., Ginini, L., & Gil, Z. (2022) · Cells · doi:10.3390/cells11091433 · Cited by 69
Metabolic reprogramming in colorectal cancer: regulatory networks and therapy
Zhang, J., Zou, S., & Fang, L. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-00977-w · Cited by 73
Guaragnella, N., Palermo, V., Galli, A., Moro, L., Mazzoni, C., & Giannattasio, S. (2013) · FEMS Yeast Research · doi:10.1111/1567-1364.12094 · Cited by 75
The metabolic cooperation between cells in solid cancer tumors
Icard, P., Kafara, P., Steyaert, J., Schwartz, L. H., & Lincet, H. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.06.002 · Cited by 74
TCA cycle signalling and the evolution of eukaryotes
Ryan, D. G., Frezza, C., & O'Neill, L. A. J. (2020) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2020.09.014 · Cited by 72
Hoerner, C. R., Chen, V. J., & Fan, A. C. (2019) · Kidney Cancer · doi:10.3233/kca-180043 · Cited by 68
Glick, G. D., Rossignol, R., Lyssiotis, C. A., Wahl, D. R., Lesch, C. A., Sanchez, B., Liu, X., Hao, L.-Y., Taylor, C. B., Hurd, A. R., et al. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.218099 · Cited by 70
Differential Aspartate Usage Identifies a Subset of Cancer Cells Particularly Dependent on OGDH
Allen, E. L., Ulanet, D., Pirman, D. A., Mahoney, C. E., Coco, J., Si, Y., Chen, Y., Huang, L., Ren, J., Choe, S. E., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.052 · Cited by 69
Wang, Z., Long, H., Chang, C., Zhao, M., & Lu, Q. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2864-2 · Cited by 69
Dong, W., Keibler, M. A., & Stephanopoulos, G. N. (2017) · Metabolic Engineering · doi:10.1016/j.ymben.2017.02.002 · Cited by 69
Thomas, D., Wu, M., Nakauchi, Y., Zheng, M., Thompson-Peach, C. A. L., Lim, K. S., Landberg, N., Köhnke, T., Robinson, N., Kaur, S., et al. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0218 · Cited by 69
Fan, J., Kamphorst, J. J., Rabinowitz, J. D., & Shlomi, T. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.502740 · Cited by 67
Peng, Y., Miao, H., Wu, S., Yang, W., Zhang, Y., Xie, G., Xie, X., Li, J., Shi, C., Ye, L., et al. (2016) · Autophagy · doi:10.1080/15548627.2016.1217380 · Cited by 67
Leithner, K., Triebl, A., Trötzmüller, M., Hinteregger, B., Leko, P., Wieser, B. I., Grasmann, G., Bertsch, A., Züllig, T., Stacher, E., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1719871115 · Cited by 69
Mitochondrial health, the epigenome and healthspan
Aon, M. A., Cortassa, S., Juhaszova, M., & Sollott, S. J. (2016) · Clinical Science · doi:10.1042/cs20160002 · Cited by 66
Iommarini, L., Calvaruso, M. A., Kurelac, I., Gasparre, G., & Porcelli, A. M. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.05.016 · Cited by 70
Cárdenas, C., Lovy, A., Silva-Pavez, E., Urra, F. A., Mizzoni, C., Ahumada-Castro, U., Bustos, G., Jaña, F., Cruz, P., Farías, P., et al. (2020) · Science Signaling · doi:10.1126/scisignal.aay1212 · Cited by 66
Zhang, C., Chen, L., Lou, W., Su, J., Huang, J., Liu, A., Xu, Y., He, H., Gao, Y., Xu, D., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abf6045 · Cited by 66
Autophagy: a targetable linchpin of cancer cell metabolism
Leone, R. D., & Amaravadi, R. K. (2013) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2013.01.008 · Cited by 68
Straub, I. R., Weraarpachai, W., & Shoubridge, E. A. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab078 · Cited by 67
The role of mitochondrial electron transport in tumorigenesis and metastasis
Tan, A. S., Baty, J. W., & Berridge, M. V. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.10.016 · Cited by 65
Metabolomics of post-mortem blood: identifying potential markers of post-mortem interval
Donaldson, A. E., & Lamont, I. L. (2014) · Metabolomics · doi:10.1007/s11306-014-0691-5 · Cited by 68
Hepatitis C virus infection triggers a tumor‐like glutamine metabolism
Levy, P. L., Duponchel, S., Eischeid, H., Molle, J., Michelet, M., Diserens, G., Vermathen, M., Vermathen, P., Dufour, J., Dienes, H., et al. (2016) · Hepatology · doi:10.1002/hep.28949 · Cited by 71
The Close Interconnection between Mitochondrial Dynamics and Mitophagy in Cancer
Bordi, M., Nazio, F., & Campello, S. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00081 · Cited by 71
Metabolic Vulnerabilities of Prostate Cancer: Diagnostic and Therapeutic OpportunitiesPreprint
Zadra, G., & Loda, M. F. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a030569 · Cited by 65
Impact of Lifestyle Behaviors on Cancer Risk and Prevention
Choi, J.-W., & Hua, T. N. M. (2021) · Journal of Lifestyle Medicine · doi:10.15280/jlm.2021.11.1.1 · Cited by 65
Peptide vaccines for the treatment of glioblastoma
Swartz, A. M., Batich, K. A., Fecci, P. E., & Sampson, J. H. (2014) · Journal of Neuro-Oncology · doi:10.1007/s11060-014-1676-y · Cited by 64
Choi, Y. W., & Lim, I. K. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.01.015 · Cited by 67
Ouyang, Q., Nakayama, T., Baytaş, O., Davidson, S. M., Yang, C., Schmidt, M., Lizarraga, S. B., Mishra, S., El‐Quessny, M., Niaz, S., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1609221113 · Cited by 66
Self-citationMitochondrial mutations and metabolic adaptation in pancreatic cancer
Initiative, A. P. C. G., Hardie, R., van Dam, E., Cowley, M. J., Han, T.-L., Balaban, S., Pajic, M., Pinese, M., Iconomou, M., Shearer, R. F., et al. (2017) · Cancer & Metabolism · doi:10.1186/s40170-017-0164-1 · Cited by 69
Rinaldi, G., Rossi, M., & Fendt, S. (2017) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1397 · Cited by 65
Bizjak, M., Malavašič, P., Dolinar, K., Pohar, J., Pirkmajer, S., & Pavlin, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-01801-5 · Cited by 66
Pachnis, P., Wu, Z., Faubert, B., Tasdogan, A., Gu, W., Shelton, S. D., Solmonson, A., Rao, A. D., Kaushik, A., Rogers, T. J., et al. (2022) · Science Advances · doi:10.1126/sciadv.abn9550 · Cited by 65
Self-citationCytosolic reducing power preserves glutamate in retina
Du, J., Cleghorn, W. M., Contreras, L., Linton, J. D., Chan, G. C. ‐., Chertov, A. O., Saheki, T., Govindaraju, V., Sadı́lek, M., Satrústegui, J., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311193110 · Cited by 62
Activation of apoptosis in NAF-1-deficient human epithelial breast cancer cells
Holt, S. H., Darash‐Yahana, M., Sohn, Y. S., Song, L., Karmi, O., Tamir, S., Michaeli, D., Luo, Y., Paddock, M. L., Jennings, P. A., et al. (2015) · Journal of Cell Science · doi:10.1242/jcs.178293 · Cited by 63
A key role for transketolase-like 1 in tumor metabolic reprogramming
Díaz‐Moralli, S., Aguilar, E., Marín, S., Coy, J. F., Dewerchin, M. A., Antoniewicz, M. R., Meca‐Cortés, Ó., Notebaert, L., Ghesquière, B., Eelen, G., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10429 · Cited by 62
Golias, T., Papandreou, I., Sun, R. C., Kumar, B., Brown, N. V., Swanson, B. J., Pai, R. K., Jaitin, D. A., Le, Q., Teknos, T. N., et al. (2016) · Scientific Reports · doi:10.1038/srep31146 · Cited by 67
Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanoma
Eskiocak, U., Ramesh, V., Gill, J. G., Zhao, Z., Yuan, S. W., Wang, M., Vandergriff, T. W., Shackleton, M. J., Quintana, E., Frankel, A. E., et al. (2016) · Nature Communications · doi:10.1038/ncomms12336 · Cited by 62
Self-citationFan, T. W. ‐., Warmoes, M. O., Sun, Q., Song, H., Turchan-Cholewo, J. T., Martin, J. T., Mahan, A. L., Higashi, R. M., & Lane, A. N. (2016) · Molecular Case Studies · doi:10.1101/mcs.a000893 · Cited by 62
Labbè, K., LeBon, L., King, B., Vu, N., Stoops, E. H., Ly, N., Lefebvre, A. E. Y. T., Seitzer, P., Krishnan, S., Heo, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52538-5 · Cited by 62
Metadata
- Authors
- Mullen, A. R., Wheaton, W. W., Jin, E. S., Chen, P.-H., Sullivan, L. B., Cheng, T., Yang, Y., Linehan, W. M., Chandel, N. S., & DeBerardinis, R. J.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Northwestern University (US)
- National Institutes of Health (US)
- Harold C. Simmons Comprehensive Cancer Center (US)
- Corresponding author
- Chandel, Navdeep S.
- DeBerardinis, Ralph J.
- ORCID
- Venue
- Nature
- Published
- 2011-11-20
- Volume
- 481
- Issue
- 7381
- Pages
- 385-388
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3262117
- OpenAlex
- W2092152920
- Cited by
- 1,328
- References
- 27
- Citations by year
- 2026: 81 · 2025: 92 · 2024: 63 · 2023: 70 · 2022: 107 · 2021: 107 · 2020: 91 · 2019: 88 · 2018: 82 · 2017: 84 · 2016: 96 · 2015: 98 · 2014: 99 · 2013: 86 · 2012: 80
- FWCI
- 29.04
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (R01CA123067, R01CA157996, T32CA009560)
- National Institute of General Medical Sciences (T32GM083831, T32GM008061)
- National Institute of Diabetes and Digestive and Kidney Diseases (K08DK072565, K01DK078933, DK078933)
- National Center for Research Resources (P41RR002584, RR‐02584)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- reductive carboxylation, glutamine metabolism, IDH1, acetyl-CoA, lipogenesis, hypoxia, tumor growth, fumarate hydratase deficiency, renal carcinoma, TCA cycle
- MeSH terms
- Acetyl Coenzyme A, Animals, Carcinoma, Renal Cell, Electron Transport, Fumarate Hydratase, Glucose, Glutamine, Humans, Isocitrate Dehydrogenase, Kidney Neoplasms, Mitochondria, NADP, Neoplasms, Electron Transport Complex III, Cell Hypoxia, Citric Acid, Electron Transport Complex I, Cell Line, Tumor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
